The development of accessible screening tools for early cancer detection in dogs represents a significant challenge in veterinary medicine. Routine laboratory data offer a promising, low-cost source for such tools, but their utility is hampered by the non-specificity of individual biomarkers and the severe class imbalance inherent in screening populations. This study assesses the feasibility of cancer risk classification using the Golden Retriever Lifetime Study (GRLS) cohort under real-world constraints, including the grouping of diverse cancer types and the inclusion of post-diagnosis samples. A comprehensive benchmark evaluation was conducted, systematically comparing 126 analytical pipelines that comprised various machine learning models, feature selection methods, and data balancing techniques. Data were partitioned at the patient level to prevent leakage. The optimal model, a Logistic Regression classifier with class weighting and recursive feature elimination, demonstrated moderate ranking ability (AUROC = 0.815; 95% CI: 0.793-0.836) but poor clinical classification performance (F1-score = 0.25, Positive Predictive Value = 0.15). While a high Negative Predictive Value (0.98) was achieved, insufficient recall (0.79) precludes its use as a reliable rule-out test. Interpretability analysis with SHapley Additive exPlanations (SHAP) revealed that predictions were driven by non-specific features like age and markers of inflammation and anemia. It is concluded that while a statistically detectable cancer signal exists in routine lab data, it is too weak and confounded for clinically reliable discrimination from normal aging or other inflammatory conditions. This work establishes a critical performance ceiling for this data modality in isolation and underscores that meaningful progress in computational veterinary oncology will require integration of multi-modal data sources.

Ewing's sarcoma (ES), characterized by a high density of small round blue cells without structural organization, presents a significant health concern, particularly among adolescents aged 10 to 19. Artificial intelligence-based systems for automated analysis of histopathological images are promising to contribute to an accurate diagnosis of ES. In this context, this study explores the feature extraction ability of different pre-training strategies for distinguishing ES from other soft tissue or bone sarcomas with similar morphology in digitized tissue microarrays for the first time, as far as we know. Vision-language supervision (VLS) is compared to fully-supervised ImageNet pre-training within a multiple instance learning paradigm. Our findings indicate a substantial improvement in diagnostic accuracy with the adaption of VLS using an in-domain dataset. Notably, these models not only enhance the accuracy of predicted classes but also drastically reduce the number of trainable parameters and computational costs.

Artificial intelligence could be twice as effective at diagnosing rare cancers as biopsies, a study found. British scientists developed a computer algorithm which correctly diagnosed the severity of sarcoma tumours in 82 per cent of cases, compared with 44 per cent of biopsies. Experts said the technique could eventually become standard practice for all cancers - saving thousands of patients from undergoing the invasive procedure every year. Such programmes will also help doctors diagnose subtypes of the disease faster and tailor treatment more effectively, they believe. Researchers used CT scans of 170 patients from the Royal Marsden, London, with sarcoma tumours, an aggressive type of cancer that develops in the body's connective tissues, such as fat, muscle and nerves.

For the first time in Australia, a Melbourne surgeon used robot technology to remove an inoperable tumor from a six-year-old girl's head, reports said Tuesday. The successful operation was recently performed on Freyja Christiansen from Canberra at the Epworth Hospital in Richmond. The six-year-old was diagnosed with a rare sarcoma near the base of her skull in December 2016, along with other tumors in her head and neck. Due to the location of the child's tumor -- between a main artery and the base of her skull -- several specialists refused to operate on her. Due to this, she underwent immunotherapy since last year, which helped shrink the tumors.